ArticleCancer research2022

Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.

Rashi Kalra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.